Event Date
November 26-27, 2026
Venue
Amsterdam, Netherlands
– Previous Conference Performers / Professionals From Around The Globe –
Media Partners/Collaborator
A huge thanks to all our amazing partners. We couldn’t have a conference without you!










Sponsors/Exhibitors
A huge thanks to all our amazing partners. We couldn’t have a conference without you!


About Conference
The 19th Edition of the International Conference on Diabetes and Endocrinology 2026 will be held on November 26-27, 2026 in Amsterdam, Netherlands, bringing together leading researchers, endocrinologists, diabetologists, and healthcare professionals from around the world. The conference will focus on the latest advancements in diabetes research, endocrine disorders, metabolic diseases, and innovative treatment strategies. Experts will share clinical studies, medical breakthroughs, and emerging technologies in endocrinology. This global event offers a valuable platform for scientific exchange, collaboration, and professional networking in diabetes and endocrine healthcare.
ICDE 2026 will focus on:
- Advances in diabetes research and treatment
- Innovations in endocrinology and hormonal therapies
- Artificial intelligence and digital health in metabolic care
- Prevention strategies and global health policies
- Translational research and clinical applications
The event will feature:
- Keynote presentations by global experts
- Plenary talks
- Oral and poster sessions
- Industry exhibitions
- Panel discussions
- Networking forums
This conference will serve as a multidisciplinary hub bringing together academia, healthcare institutions, pharmaceutical companies, and biotech industries.
Who Should Attend?
ICDE 2026 is ideal for:
- Endocrinologists
- Diabetologists
- Physicians & Surgeons
- Clinical Researchers
- Medical Scientists
- Public Health Professionals
- Nutritionists & Dietitians
- Diabetes Educators
- Pharmaceutical & Biotech Professionals
- Medical Device Manufacturers
- Healthcare Policy Makers
- Academic Faculty & Students
- Research Scholars
🎯 Conference Benefits
Attendees will gain:
✅ Scientific Advancement
- Exposure to the latest research findings
- Access to unpublished data and clinical trial updates
- Insights into global best practices
✅ Networking Opportunities
- Meet world-renowned experts
- Connect with potential collaborators
- Establish partnerships with industry leaders
✅ Professional Development
- Present your research to an international audience
- Receive constructive feedback from experts
- Earn conference certification
✅ Business & Industry Exposure
- Discover emerging technologies
- Connect with pharmaceutical and device companies
- Explore investment and funding opportunities
Scientific Sessions & Tracks
Latest discoveries in pathophysiology and molecular mechanisms.
Autoimmune mechanisms, genetics, and emerging therapies.
Insulin resistance, lifestyle management, and pharmacological treatments.
Maternal-fetal health, screening protocols, and prevention.
Growth disorders, juvenile diabetes, and hormonal imbalances.
Epidemiology, prevention, and therapeutic interventions.
Hyperthyroidism, hypothyroidism, thyroid cancer, and management strategies.
Cushing’s syndrome, Addison’s disease, adrenal tumors.
Acromegaly, prolactinomas, and hormonal regulation.
PCOS, infertility, and hormonal therapies.
Osteoporosis, calcium disorders, vitamin D deficiency.
Neuropathy, nephropathy, retinopathy, cardiovascular risks.
Hypertension, lipid disorders, integrated care approaches.
AI-driven diagnostics and predictive analytics.
Continuous glucose monitoring, remote patient care.
Genomics and personalized treatment strategies.
Novel therapeutics and regulatory updates.
Dietary management and exercise protocols.
Global diabetes trends and prevention strategies.
Biotechnology, regenerative medicine, and stem cell therapy.
Market Analysis
Global Diabetes Market
- The global diabetes market is projected to exceed USD 150 billion by 2030.
- Increasing prevalence of Type 2 diabetes due to sedentary lifestyles.
- Rising demand for insulin delivery systems and glucose monitoring devices.
- Growth in digital therapeutics and telemedicine.
Endocrinology Therapeutics Market
- Expansion in hormonal therapy drugs.
- Increasing adoption of AI-based diagnostic tools.
- Rapid growth in personalized medicine.
- Strong investment in biotech innovation.
Key Drivers
- Aging population
- Urbanization
- Rising obesity rates
- Technological innovation
- Government health initiatives
ICDE 2026 provides a critical platform for stakeholders to explore these growing opportunities.
Venue Information
Amsterdam, the vibrant capital of Netherlands, is one of Europe’s leading destinations for international conferences, scientific research, and innovation. Renowned for its picturesque canals, historic architecture, and welcoming multicultural atmosphere, Amsterdam seamlessly blends centuries of heritage with modern advancements in healthcare, technology, and life sciences. The city is home to world-class universities, academic medical centers, and internationally recognized research institutions, making it an ideal venue for global medical and scientific meetings. Visitors can explore iconic attractions such as the Rijksmuseum, Dam Square, and the charming canal district, a UNESCO World Heritage-listed Canal Ring. With excellent international connectivity through Amsterdam Airport Schiphol, an efficient public transportation system, exceptional hotels, and a thriving culinary and cultural scene, Amsterdam offers delegates an outstanding environment for professional networking, scientific collaboration, and memorable travel experiences. Hosting the 19th Edition of International Conference on Diabetes and Endocrinology 2026 in Amsterdam provides participants with the perfect opportunity to engage in cutting-edge scientific discussions while experiencing one of Europe’s most dynamic and inspiring cities.
– Tracks & Key Topics –
-
Diabetes
-
Diabetes mellitus
-
Type 1 diabetes
-
Type 2 diabetes
-
Gestational diabetes
-
Prediabetes
-
Hyperglycemia
-
Hypoglycemia
-
Insulin resistance
-
Insulin therapy
-
Blood glucose monitoring
-
Continuous glucose monitoring
-
Glycemic control
-
HbA1c
-
Diabetic complications
-
Diabetic neuropathy
-
Diabetic nephropathy
-
Diabetic retinopathy
-
Cardiovascular complications in diabetes
-
Metabolic syndrome
-
Obesity and diabetes
-
Pediatric diabetes
-
Adult-onset diabetes
-
Endocrine disorders
-
Pancreatic beta cells
-
Glucose metabolism
-
Lipid metabolism
-
Diabetes prevention
-
Diabetes management
-
Diabetes education
-
Lifestyle intervention
-
Medical nutrition therapy
-
Physical activity and diabetes
-
Oral antidiabetic drugs
-
Injectable diabetes medications
-
Insulin pumps
-
Closed-loop insulin systems
-
Precision medicine in diabetes
-
Personalized diabetes care
-
Digital diabetes management
-
Telemedicine for diabetes
-
Artificial intelligence in diabetes care
-
Diabetes clinical trials
-
Epidemiology of diabetes
-
Global diabetes burden
-
Diabetes screening
-
Early diagnosis of diabetes
-
Beta-cell dysfunction
-
Autoimmune diabetes
-
Latent autoimmune diabetes in adults (LADA)
-
Diabetic ketoacidosis
-
Hyperosmolar hyperglycemic state
-
Microvascular complications
-
Macrovascular complications
-
Diabetes and hypertension
-
Diabetes and dyslipidemia
-
Pregnancy and diabetes
-
Diabetes self-management
-
Nutrition and diabetes
-
Long-term diabetes outcomes











































